Chemoinformaics analysis of GLUCOSAMINE-SULFATE
Molecular Weight | 277.251 | nRot | 5 |
Heavy Atom Molecular Weight | 262.131 | nRig | 1 |
Exact Molecular Weight | 277.047 | nRing | 0 |
Solubility: LogS | -0.073 | nHRing | 0 |
Solubility: LogP | -2.841 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 31.2399 |
nHD | 7 | BPOL | 22.0021 |
QED | 0.28 |
Synth | 4.182 |
Natural Product Likeliness | 2.091 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.172 |
HIA | 0.79 |
CACO-2 | -5.268 |
MDCK | 0.00465902 |
BBB | 0.161 |
PPB | 0.246529 |
VDSS | 0.555 |
FU | 0.752902 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.024 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.057 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.076 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.143 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.02 |
CL | 1.903 |
T12 | 0.748 |
hERG | 0.104 |
Ames | 0.084 |
ROA | 0.017 |
SkinSen | 0.137 |
Carcinogencity | 0.007 |
EI | 0.017 |
Respiratory | 0.393 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.766835 |